 | Up a level |
Ehret, Felix; Rueß, Daniel; Blanck, Oliver; Fichte, Susanne; Chatzikonstantinou, Georgios; Wolff, Robert; Mose, Lucas; Mose, Stephan; Fortmann, Thomas; Lehrke, Ralph; Turna, Menekse; Caglar, Hale Basak; Mortasawi, Farshin; Bleif, Martin; Krug, David; Ruge, Maximilian I; Fürweger, Christoph; Muacevic, Alexander (2024). Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis. (In Press). International journal of cancer Wiley 10.1002/ijc.34980
Shelan, Mohamed; Achard, Vérane; Appiagyei, Felix; Mose, Lucas; Zilli, Thomas; Fankhauser, Christian D; Zamboglou, Constantinos; Mohamad, Osama; Aebersold, Daniel M; Cathomas, Richard (2024). Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. (In Press). Prostate cancer and prostatic diseases Nature 10.1038/s41391-024-00829-9
Schröder, Christina; Mose, Lucas; Mathier, Etienne; Zwahlen, Daniel Rudolf; Aebersold, Daniel Matthias; Förster, Robert; Shelan, Mohamed (2023). Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers, 15(24) MDPI AG 10.3390/cancers15245815
Schröder, Christina; Mose, Lucas; Förster, Robert; Mathier, Etienne; Zwahlen, Daniel R.; Aebersold, D. M.; Shelan, Mohamed (2023). Five fractions versus seven fractions SBRT for intermediate and high risk prostate cancer: a propensity score matched pair analysis. Strahlentherapie und Onkologie, 11(199), p. 1049. Springer
